These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 19797556)

  • 41. Treating low- and medium-potency bisphosphonate-related osteonecrosis of the jaws with a protocol for the treatment of chronic suppurative osteomyelitis: report of 7 cases.
    Alons K; Kuijpers SC; de Jong E; van Merkesteyn JP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Feb; 107(2):e1-7. PubMed ID: 19071040
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiresorptive drug-related osteonecrosis of the jaw.
    Uyanne J; Calhoun CC; Le AD
    Dent Clin North Am; 2014 Apr; 58(2):369-84. PubMed ID: 24655528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Osteonecrosis of the jaws secondary to bisphosphonate therapy: a case series.
    Kumar SK; Meru M; Sedghizadeh PP
    J Contemp Dent Pract; 2008 Jan; 9(1):63-9. PubMed ID: 18176650
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bisphosphonate and nonbisphosphonate-associated osteonecrosis of the jaw: a review.
    Almazrooa SA; Woo SB
    J Am Dent Assoc; 2009 Jul; 140(7):864-75. PubMed ID: 19571050
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of patients on bisphosphonates and prevention of bisphosphonate-related osteonecrosis of the jaw.
    Chu V; ;
    Hawaii Dent J; 2008; 39(5):9-12; quiz 17. PubMed ID: 19189512
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
    Carlson ER; Basile JD
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bisphosphonate-induced osteonecrosis of the jaw.
    Krueger CD; West PM; Sargent M; Lodolce AE; Pickard AS
    Ann Pharmacother; 2007 Feb; 41(2):276-84. PubMed ID: 17299010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Bisphosphonate-associated osteonecrosis of the jaws. 3. Two case reports].
    Schortinghuis J; Meijndert L; de Visscher JG; Witjes MJ
    Ned Tijdschr Tandheelkd; 2007 Oct; 114(10):432-5. PubMed ID: 17972612
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Msx-1 is suppressed in bisphosphonate-exposed jaw bone analysis of bone turnover-related cell signalling after bisphosphonate treatment.
    Wehrhan F; Hyckel P; Amann K; Ries J; Stockmann P; Schlegel K; Neukam F; Nkenke E
    Oral Dis; 2011 May; 17(4):433-42. PubMed ID: 21366807
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bisphosphonate-induced osteonecrosis: dental considerations.
    Gross HB
    Compend Contin Educ Dent; 2008 Mar; 29(2):112-3. PubMed ID: 18429426
    [No Abstract]   [Full Text] [Related]  

  • 51. [Bisphosphonate-induced jaw osteonecrosis--prevention and treatment].
    ; ; ; ;
    Orv Hetil; 2010 Jan; 151(4):148-9. PubMed ID: 20071321
    [No Abstract]   [Full Text] [Related]  

  • 52. Dental sinus tracts mimicking scrofuloderma: cutaneous presentation of underlying bisphosphonate-related osteonecrosis of the jaw.
    Kang HS; Lee JW; Kim JS
    Clin Exp Dermatol; 2011 Aug; 36(6):624-7. PubMed ID: 21771007
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk of osteonecrosis of the jaw in cancer patients taking bisphosphonates.
    Gebara SN; Moubayed H
    Am J Health Syst Pharm; 2009 Sep; 66(17):1541-7. PubMed ID: 19710437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Quality of life implications of bisphosphonate-associated osteonecrosis of the jaw.
    Miksad RA; Lai KC; Dodson TB; Woo SB; Treister NS; Akinyemi O; Bihrle M; Maytal G; August M; Gazelle GS; Swan JS
    Oncologist; 2011; 16(1):121-32. PubMed ID: 21212433
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple osteonecrosis of the jaw, oral bisphosphonate therapy and refractory rheumatoid arthritis (Pathological fracture associated with ONJ and BP use for osteoporosis).
    Grana J; Mahia IV; Meizoso MO; Vazquez T
    Clin Exp Rheumatol; 2008; 26(2):384-5. PubMed ID: 18565271
    [No Abstract]   [Full Text] [Related]  

  • 56. Osteonecrosis of the jaw associated with bisphosphonate use: Presentation of seven cases and literature review.
    Mortensen M; Lawson W; Montazem A
    Laryngoscope; 2007 Jan; 117(1):30-4. PubMed ID: 17202926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bisphosphonates and jaw osteonecrosis: the UAMS experience.
    Clarke BM; Boyette J; Vural E; Suen JY; Anaissie EJ; Stack BC
    Otolaryngol Head Neck Surg; 2007 Mar; 136(3):396-400. PubMed ID: 17321866
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ozone therapy in the treatment of avascular bisphosphonate-related jaw osteonecrosis.
    Agrillo A; Ungari C; Filiaci F; Priore P; Iannetti G
    J Craniofac Surg; 2007 Sep; 18(5):1071-5. PubMed ID: 17912085
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bisphosphonates and the dental practitioner--a guide to management.
    Williamson R
    Ann R Australas Coll Dent Surg; 2010 Mar; 20():46-9. PubMed ID: 22046734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases.
    Stanton DC; Balasanian E
    J Oral Maxillofac Surg; 2009 May; 67(5):943-50. PubMed ID: 19375001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.